RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM) Antimicrobial Wound GelThis is an important milestone that allows a launch of a new product to Canadian consumers and a chance to demonstrate a working model for future commercializations. I have always been a firm believer that a BioTech must not stop at the responsibility of discovering and developing up scale of a new product but also must understand it is their obligation to see it gets into the hands of the consumer. Lets hope that the marketing and sales divisions ramp up quickly. Marc shoul of already developed materials in preparation. The first 9 months post launch are critical and an impactful plan must be in place